Nektar Therapeutics (NKTR) Tops Q3 EPS by 22c
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Price: $73.02 --0%
Financial Fact:
Total non-operating expense: -10.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total non-operating expense: -10.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q3 EPS of $0.39, $0.22 better than the analyst estimate of $0.17. Revenue for the quarter came in at $152.9 million versus the consensus estimate of $114.62 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
